A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)

Peer Review reports

Original Submission
10 Aug 2021	Submitted	Original manuscript
17 Oct 2021	Reviewed	Reviewer Report - Alexander Gough
12 Jan 2022	Reviewed	Reviewer Report - Patrick Harris
10 Feb 2022	Author responded	Author comments - Aurema Otero González
Resubmission - Version 2
10 Feb 2022	Submitted	Manuscript version 2
Publishing
26 Mar 2022	Editorially accepted
12 Apr 2022	Article published	10.1186/s13063-022-06219-7

Back to article page